Alliance for mRNA Medicines
Become a Member

La Jolla Labs

Tamar Grossman, PhD

CEO & Co-Founder
La Jolla Labs
  • La Jolla Labs, founded in 2021, is a cutting-edge biotechnology company revolutionizing RNA-based therapeutics through its proprietary AI-powered platform that accelerates the discovery of drug candidates targeting novel RNA mechanisms.
  • La Jolla Labs has developed a differentiated platform that rapidly and cost-efficiently advances therapeutics from early research through preclinical and clinical stages, often in under a year, with deep expertise in rare diseases and individualized treatments.
  • La Jolla Labs proprietary AI-driven software streamlines the design of RNA therapies, enabling precise modulation of gene expression via inhibition, upregulation, splicing modulation, and allele-specific targeting.
  • This innovative approach aims to deliver effective treatments for complex diseases, including neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Amyotrophic lateral sclerosis.